Sorry, I didn't mean to type that CoviDx was a consumer self-test. Thats incorrect. I will delete post.
I was trying to indicate that its a RAT design, with no instruments like additional reader required for ADO test. So from TGA approval, criteria and usage requirements, its stands a much easier chance of approval considering the demand for high volumes of tests currently (and gov procurement costs would be potentially lower too per test since the expensive reader is not a necessary component).
Sorry, I didn't mean to type that CoviDx was a consumer...
Add LDX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.9¢ |
Change
-0.001(2.00%) |
Mkt cap ! $22.62M | |||
| Open | High | Low | Value | Volume |
| 4.8¢ | 4.9¢ | 4.6¢ | $76.97K | 1.624M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 247200 | 4.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 328316 | 2 |
View Market Depth
| Last trade - 16.10pm 02/05/2024 (20 minute delay) ? |
|
|||||
|
Last
4.8¢ |
Change
-0.001 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 4.8¢ | 5.0¢ | 4.6¢ | 952580 | ||
| Last updated 15.59pm 02/05/2024 ? | |||||
| LDX (ASX) Chart |